180 related articles for article (PubMed ID: 24074562)
1. The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines.
Mack HI; Munger K
Virology; 2013 Nov; 446(1-2):9-16. PubMed ID: 24074562
[TBL] [Abstract][Full Text] [Related]
2. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism.
Zeng Q; Chen J; Li Y; Werle KD; Zhao RX; Quan CS; Wang YS; Zhai YX; Wang JW; Youssef M; Cui R; Liang J; Genovese N; Chow LT; Li YL; Xu ZX
Oncogene; 2017 Mar; 36(9):1245-1255. PubMed ID: 27546620
[TBL] [Abstract][Full Text] [Related]
3. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract][Full Text] [Related]
4. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
5. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
[TBL] [Abstract][Full Text] [Related]
7. LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation.
Zulato E; Ciccarese F; Agnusdei V; Pinazza M; Nardo G; Iorio E; Curtarello M; Silic-Benussi M; Rossi E; Venturoli C; Panieri E; Santoro MM; Di Paolo V; Quintieri L; Ciminale V; Indraccolo S
Biochem Pharmacol; 2018 Oct; 156():479-490. PubMed ID: 30222967
[TBL] [Abstract][Full Text] [Related]
8. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
9. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
Scott KD; Nath-Sain S; Agnew MD; Marignani PA
Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor kinase LKB1: lessons from mouse models.
Ollila S; Mäkelä TP
J Mol Cell Biol; 2011 Dec; 3(6):330-40. PubMed ID: 21926085
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
12. The molecular mechanisms that underlie the tumor suppressor function of LKB1.
Fan D; Ma C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):97-107. PubMed ID: 19204826
[TBL] [Abstract][Full Text] [Related]
13. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.
Nafz J; De-Castro Arce J; Fleig V; Patzelt A; Mazurek S; Rösl F
Biochem J; 2007 May; 403(3):501-10. PubMed ID: 17212587
[TBL] [Abstract][Full Text] [Related]
14. Endogenous LKB1 knockdown accelerates G(1)/S transition through p53 and p16 pathways.
Liang X; Wang P; Gao Q; Xiang T; Tao X
Cancer Biol Ther; 2010 Jan; 9(2):156-60. PubMed ID: 20368693
[TBL] [Abstract][Full Text] [Related]
15. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
[TBL] [Abstract][Full Text] [Related]
16. Effects of Peutz-Jeghers syndrome (PJS) causing missense mutations L67P, L182P, G242V and R297S on the structural dynamics of LKB1 (Liver kinase B1) protein.
Rungsung I; Ramaswamy A
J Biomol Struct Dyn; 2019 Feb; 37(3):796-810. PubMed ID: 29447078
[TBL] [Abstract][Full Text] [Related]
17. LKB1 and cancer: The dual role of metabolic regulation.
Li TT; Zhu HB
Biomed Pharmacother; 2020 Dec; 132():110872. PubMed ID: 33068936
[TBL] [Abstract][Full Text] [Related]
18. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.
Tiainen M; Ylikorkala A; Mäkelä TP
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9248-51. PubMed ID: 10430928
[TBL] [Abstract][Full Text] [Related]
19. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
Lin-Marq N; Borel C; Antonarakis SE
Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
[TBL] [Abstract][Full Text] [Related]
20. The LKB1 tumor suppressor kinase in human disease.
Katajisto P; Vallenius T; Vaahtomeri K; Ekman N; Udd L; Tiainen M; Mäkelä TP
Biochim Biophys Acta; 2007 Jan; 1775(1):63-75. PubMed ID: 17010524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
